Migraine: Definitions, mechanisms, and treatment

Southern Medical Journal

Volumn 89, Issue 8, 1996, Pages 762-769

  Noack, Howard ^a   Rothrock, John F ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

^c UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; CHLORPROMAZINE; ERGOTAMINE TARTRATE; KETOROLAC; METHYSERGIDE; METOCLOPRAMIDE; NADOLOL; NAPROXEN; PROCHLORPERAZINE; PROPRANOLOL; SUMATRIPTAN; VALPROATE SEMISODIUM; VERAPAMIL;

CLINICAL PRACTICE; DOSE CALCULATION; DRUG EFFICACY; HUMAN; MIGRAINE; ORAL DRUG ADMINISTRATION; PREVALENCE; PROPHYLAXIS; REVIEW; SEROTONIN RELEASE;

EID: 0029795326     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199608000-00002     Document Type: Review

References (78)

1. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(suppl):1-96
2. Lipton R, Stewart W: Migraine in the United States: a review of epidemiology and health care use. Neurology 1993; 43(suppl):S6-S10
3. Osterhaus J, Gutterman D, Plachetka J: Healthcare resource and lost labor costs of migraine headache in the United States. Pharmacol Economics 1992; 2:67-70
4. DeLissovoy G, Lazaru S: The economic cost of migraine. present state of knowledge: Neurology 1994; 44(suppl):556-562
5. Ad Hoc Committee on Classification of Headache: Classification of headache. JAMA 1962; 179:717-718
6. Stewart W, Lipton R, Shechter A: Validity of diagnostic criteria for migraine (Abstract). Neurology 1994; 44(suppl): A170
7. Tom T, Brody M, Valabhji A, et al: Validation of a new instrument for determining migraine prevalence: the UCSD migraine questionnaire. Neurology 1994; 44:925-928
8. Granella F, D'Alessandro R, Manzoni G, et al: International Headache Society classification: interobserver reliability in the diagnosis of primary headaches. Cephalalgia 1994; 14:16-20
9. Wolff HG, Tunis MM: Analysis of cranial artery pressure pulse waves in patients with vascular headache of the migraine type. Trans Assoc Am Physicians 1952; 65:240-244
10. Leao A: Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7:359-390
11. Leao A: Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7:391-463
12. Leao A, Morison RS: Propagation of spreading cortical depression. J Neurophysiol 1945; 8:33-45
13. Milner PM: Note on a possible correspondence between the scotomas of migraine and spreading depression of Leao. Electroencephalogr Clin Neurophysiol 1958; 10:705
14. Lashley KS: Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941; 46:331-339
15. Lauritzen M, Jorgensen MB, Diemer NH, et al: Persistent oligemia of rat cerebral cortex in the wake of spreading depression. Ann Neurol 1982; 12:469-474
16. 2 response. J Cereb Blood Flow Metab 1984; 4:546-554
17. + during spreading depression. Acta Physiol Scand 1988; 109:1-6
18. Lauritzen M: Regional cerebral blood flow during cortical spreading depression in rat brain: increased reactive hyperperfusion in low-flow states. Acta Neurol Scand 1987; 75:1-8
19. Olesen J, Larsen B, Lauritzen M: Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9:344-352
20. Lauritzen M, Olsen TS, Lassen NA, et al: Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983; 13:633-641
21. Lauritzen M, Olsen TS, Lassen NA, et al: Regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983; 14:569-572
22. Lauritzen M, Olesen J: Regional cerebral blood flow during migraine attacks by xenon-133 inhalation and emission tomography. Brain 1984; 107:447-461
23. Skyhoj Olsen T, Lauritzen M, Lassen N: Focal ischemia during migraine attacks in patients with classical and complicated migraine. Acta Neurol Scand 1984; 69(suppl):258-259
24. Andersen AR, Friberg L, Olsen TS, et al: Delayed hyperemia following hypoperfusion in classic migraine: single photon emission computed tomographic demonstration. Arch Neurol 1988; 45:154-159
25. Olesen J, Friberg L, Olsen TS, et al: Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990; 28:791-798
26. Friberg L: Cerebral blood flow changes in migraine: methods, observations and hypotheses. J Neurol 1991; 238:812-817
27. Welch K, Barkley G, Tepley N, et al: Central neurogenic mechanisms of migraine. Neurology 1993; 43(suppl):S21-S25
28. Moskowitz MA: The neurobiology of vascular head pain. Ann Neurol 1984; 16:157-168
29. Moskowitz MA: The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991; 41:182-186
30. Mayberg M, Langer R, Zervas N, et al: Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science 1981; 213:228-230
31. Moskowitz MA: Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992; 13:307-311
32. Sagar SM, Sharp FR, Curran T: Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 1988; 240:1328-1331
33. Moskowitz MA, Nozaki K, Kraig RP: Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993; 13:1167-1177
34. Sicuteri F, Testi A, Anselmi B: Biochemical investigations in headache: increase in hydroxyindoleacetic acid excretion during migraine attacks. Int Arch Allergy Appl Immunol 1961; 19:55-58
35. Curran DA, Hinterberger H, Lance JW: Total plasma serotonin, 5-hydroxyindoleacetic acid and p-hydroxy-m-methoxymandelic acid excretion in normal and migrainous subjects. Brain 1965; 88:997-1010
36. Anthony M, Hinterberger H, Lance JW: Plasma serotonin in migraine and stress. Arch Neurol 1967; 16:544-552
37. Somerville BW: Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine. Neurology 1976; 26:41-45
38. Anthony M, Lance J: The role of serotonin in migraine. Modern Topics in Migraine. Pearce J (ed). London, William Heinemann Medical Books Ltd, 1975, pp 107-123
39. MacKenzie ET, Edvinsson L, Scatton B: Functional bases for a central serotoninergic involvement in classic migraine: a speculative view. Cephalalgia 1985; 5:69-78
40. Spira PJ, Mylecharane EJ, Misback J, et al: Internal and external carotid vascular responses to vasoactive agents in the monkey. Neurology 1978; 25:162-173
41. Hardebo JE, Edvinsson L, Owman C, et al: Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels: possible implications in migraine. Neurology 1978; 28:64-70
42. Kimball RW, Friedman AP, Vallejo E: Effect of serotonin in migraine patients. Neurology (NY) 1960; 10:107-111
43. Lance JW, Anthony M, Hinterberger H: The control of cranial arteries by humoral mechanisms and its relation to the migraine syndrome. Headache 1967; 7:93-102
44. Biegon A, Reches A, Snyder L, et al: Serotoninergic and noradrenergic receptors in the rat brain: modulation by chronic exposure to ovarian hormones. Life Sci 1983; 32:2015-2021
45. Wong F: Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984; 226:1393-1396
46. Aghajanian GK: The modulatory role of serotonin at multiple receptors in brain. Serotonin Neurotransmission and Behavior. Jacobs BL, Gelperin A (eds). Cambridge, Mass, MIT Press, 1981, pp 156-185
47. Blau JN: Resolution of migraine attacks: sleep and the recovery phase. J Neruol Neurosurg Psychiatry 1982; 45:223-226
48. Quay WB, Meyer DC: Rhythmicity and periodic functions of the central nervous system and serotonin. Serotonin in Health and Disease, Volume 11: Physiological Regulation and Pharmacological Action. Essman WB (ed). New York, Spectrum Publications, 1978, pp 159-204
49. Raskin N: Headache. New York, Churchill-Livingstone, 1988, pp 160-164
50. Anthony M, Hinterberger H, Lance JW: The possible relationship of serotonin to the migraine syndrome. Research and Clinical Studies in Headache. Friedman AP (ed). New York, S Karger, Vol 2, 1969, pp 29-59
51. Welch KMA: Migraine: a biobehavioral disorder. Arch Neurol 1987; 44:323-327
52. Sicuteri F: Migraine, a central biochemical dysnociception. Headache 1976; 16:145-159
53. Lance JW: Current concepts of migraine pathogenesis. Neurology 1993; 43(suppl):S11-S15
54. Mathew N, Stubits E, Nigam M: Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982; 22:66-68
55. Mathew N, Reuveni U, Perez F: Transformed or evolutive migraine. Headache 1987; 27:102-106
56. Mathew N: Transformed migraine. Cephalalgia 1993; 12(suppl):78-83
57. Peroutka S: Developments in 5-hydroxytryptamine receptor pharmacology in migraine. Neurol Clin 1990; 8:829-839
58. 2 receptor antagonists and migraine therapy. J Neurol 1991; 238(suppl):545-552
59. Couch J, Hassanein RS: Amitriptyline in migraine prophylaxis. Arch Neurol 1979; 36:695-699
60. Weber R, Reinmuth O: The treatment of migraine with propranolol. Neurology 1972; 22:366-396
61. Wideroe T, Vigander T: Propranolol in the treatment of migraine. BMJ 1974; 2:699-701
62. Welch K: Drug therapy of migraine. N Engl J Med 1993; 329:1476-1483
63. Nishikawa T, Scatton B: Inhibitory influence of GABA on central serotoninergic transmission, raphe nuclei as the neuroanatomical site of the GABAergic inhibition of cerebral serotoninergic neurons. Brain Res 1985; 331:91-103
64. Henry R, Kuritzky A: Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992; 12:81-84
65. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994; 44:647-651
66. Mathew N, Saper J, Silberstein S, et al: Migraine prophylaxis with divalproex. Arch Neurol 1995; 52:281-286
67. Tfelt-Hansen P, Olesen J: Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia 1984; 4:107-111
68. Johnson E, Ratcliffe D, Wilkinson M: Naproxen sodium in the treatment of migraine. Cephalalgia 1985; 5:5-10
69. Kloster R, Nestvold K, Vilming S: A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia 1992; 12:169-171
70. Selby G, Lance J: Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry 1960; 23:23-32
71. Subcutaneous Sumatriptan International Study Group: Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325:316-321
72. Cady R, Wendt J, Kirchner J, et al: Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265:2831-2835
73. Oral Sumatriptan International Multiple-Dose Study Group: Evaluation of a multiple dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31:306-313
74. Saadah H: Abortive headache therapy in the office with intravenous dihydroergotamine in the treatment of acute migraine headache. Headache 1992; 32:143-146
75. Hoffert M, Couch J, Diamond S, et al: Transnasal butorphanol in the treatment of acute migraine. Headache 1995; 35:65-69
76. Tek D, McClellan D, Olshaker J, et al: A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med 1990; 19:1083-1087
77. Lane P, McLellan B, Baggoley C: Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann EmergMed 1989; 18:360-365
78. Jones S, Sklar D, Dougherty J, et al: Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989; 261:1174-1176